Boston Scientific Gains Majority Stake in Partner M.I.Tech for $230M

In a half year that has turned heads with milestone medtech deals popping up by the dozen—including Stryker’s $2.97 billion buyout of Vocera Communications, Becton Dickinson’s stated intention to purchase Parata for $1.53 billion, and ResMed’s $1 billion MediFox Dan acquisition—Boston Scientific isn’t going to let 2022 conclude without making its own historic investment...